Trinity Biotech PLC expected to post a loss of 4  cents a share - Earnings Preview

Trinity Biotech

17/06/2022 12:01

* Trinity Biotech PLC  TRIB.OQ   TRIB.O  is expected to show
a
fall in quarterly revenue when it reports  results on June 20
(estimated). 
    * The Bray Wicklow-based  company is expected to report  a
21.9% decrease in revenue to $20 million from $25.59 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Trinity Biotech PLC
is
for a loss of 4 cents per share. For the same quarter last year,
the company reported earnings of 10 cents per share.
    * The one available analyst rating on the shares is "strong
buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Trinity
Biotech
PLC is $4​, above​ its last closing price of $1.21. ​​​

This summary was machine generated June 17 at 11:00 GMT.  All
figures in US dollars  unless otherwise stated